D360 Scientific Informatics Discovery Platform: User Stories
Transcript: I've joined companies both blueprint medicines and score therapeutics is one of the first…
Certara2024 年 2 月 8 日
Upping the Ante for Predicting the Success of Alzheimer Disease Treatments
By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years,…
Certara2024 年 2 月 8 日
Drug Development’s New Model: Biosimulation from Discovery to Label Expansion
Key Highlights: How predictive technologies reshape drug development, mitigating project risks, navigating novel biomarkers, predicting…
Certara2024 年 2 月 2 日
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader…
Certara2024 年 2 月 1 日
Navigating Market Access for Healthcare Products: The Power of the Global Value Dossier
This blog defines the global value dossiers and explains how BaseCase can support creating interactive…
Certara2024 年 1 月 24 日
Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products
Join us to understand the dynamics of the pharmaceutical market and learn how to maintain…
Certara2024 年 1 月 24 日
Understanding the Role of Your Discovery Asset’s Target Product Profile
If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…
Certara2024 年 1 月 19 日
Streamlining Your NCA Workflow
准备递交的 PK 分析面临着许多数据和合规方面的挑战。To work efficiently,…
Certara2024 年 1 月 18 日
